Population‐Based Study on the Coexistence of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Chronic Kidney Disease
MASLD(+)/CKD(+) phenotype increases the risk of cardiometabolic multimorbidity and independently predicts mortality. Mortality risk increased progressively in individuals with both advanced hepatic fibrosis and CKD.
Authors
- Yip Han Chin (ORCID: https://orcid.org/0000-0002-8417-5996)
- Gwyneth Kong (ORCID: https://orcid.org/0000-0002-3385-5078)
- Jobelle Chia
- Bryan Chong (ORCID: https://orcid.org/0000-0002-3565-7657)
- Muhammad Shahzeb Khan (ORCID: https://orcid.org/0000-0003-1250-6351)
- Mark Dhinesh Muthiah (ORCID: https://orcid.org/0000-0002-9724-4743)
- Mark Y. Chan (ORCID: https://orcid.org/0000-0003-0389-7450)
- Anurag Mehta (ORCID: https://orcid.org/0000-0002-6910-5551)
- Nicholas Chew (ORCID: https://orcid.org/0000-0002-0640-0430)
- Rachel Sze Jen Goh (ORCID: https://orcid.org/0009-0007-1875-8257)
- Jaycie Koh
- Made Ayu Utami Intaran
Institutions
- National University of Singapore (SG)
- Nanyang Technological University (SG)
- Baylor College of Medicine (US)
- Virginia Commonwealth University (US)
- Temple College (US)
- University Health System (US)
- National University Heart Centre Singapore (SG)
- Baylor Medical Center at Garland (US)
- Heart Hospital Baylor Plano (US)
- Plano Cancer Institute (US)
- National University Hospital (SG)
- National University Health System (SG)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1161/jaha.125.041834
- Citations
- 5
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.77